136 related articles for article (PubMed ID: 1725400)
1. Development and application of three radioimmunoassays of endothelin of varying specificities.
Capper SJ; Ella SJ; Kalinka S
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S425-6. PubMed ID: 1725400
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical localization of endothelin peptides, precursors, and endothelin-converting enzymes.
Kuc RE
Methods Mol Biol; 2002; 206():3-19. PubMed ID: 12152232
[No Abstract] [Full Text] [Related]
3. Analysis of big endothelin-1 digestion by cathepsin D.
Sawamura T; Shinmi O; Kishi N; Sugita Y; Yanagisawa M; Goto K; Masaki T; Kimura S
Biochem Biophys Res Commun; 1990 Oct; 172(2):883-9. PubMed ID: 2241976
[TBL] [Abstract][Full Text] [Related]
4. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway.
Yorimitsu K; Shinmi O; Nishiyama M; Moroi K; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S
FEBS Lett; 1992 Dec; 314(3):395-8. PubMed ID: 1468574
[TBL] [Abstract][Full Text] [Related]
5. Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans.
Plumpton C; Haynes WG; Webb DJ; Davenport AP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S34-6. PubMed ID: 8587408
[TBL] [Abstract][Full Text] [Related]
6. Localization of endothelin-converting enzyme in bovine optic nerve and retina.
Dibas A; Prasanna G; Yorio T
J Ocul Pharmacol Ther; 2005 Aug; 21(4):288-97. PubMed ID: 16117692
[TBL] [Abstract][Full Text] [Related]
7. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage.
Juvela S
J Neurosurg; 2002 Dec; 97(6):1287-93. PubMed ID: 12507125
[TBL] [Abstract][Full Text] [Related]
8. D-Val22 containing human big endothelin-1 analog, [D-Val22]Big ET-1[16-38], inhibits the endothelin converting enzyme.
Morita A; Nomizu M; Okitsu M; Horie K; Yokogoshi H; Roller PP
FEBS Lett; 1994 Oct; 353(1):84-8. PubMed ID: 7926029
[TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacology of endothelin converting enzymes.
Turner AJ; Murphy LJ
Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
[TBL] [Abstract][Full Text] [Related]
10. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
[TBL] [Abstract][Full Text] [Related]
11. Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1.
Takayanagi R; Liu W; Ito T; Ohnaka K; Nawata H
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S62-3. PubMed ID: 9595401
[TBL] [Abstract][Full Text] [Related]
12. Sandwich-enzyme immunoassays for endothelin family peptides.
Suzuki N; Matsumoto H; Miyauchi T; Kitada C; Tsuda M; Goto K; Masaki T; Fujino M
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S420-2. PubMed ID: 1725398
[TBL] [Abstract][Full Text] [Related]
13. Disulfide bonds in big ET-1 are essential for the specific cleavage at the Trp(21)-Val(22) bond by soluble endothelin converting enzyme-1 from baculovirus/insect cells.
Fahnoe DC; Johnson GD; Herman SB; Ahn K
Arch Biochem Biophys; 2000 Jan; 373(2):385-93. PubMed ID: 10620363
[TBL] [Abstract][Full Text] [Related]
14. [Phe21]big endothelin-1(18-34) and [Ala31]big endothelin-1(18-34) inhibit the human endothelin-converting enzyme-1 (ECE-1) expressed in CHO-K1 cells in a different fashion.
Liu W; Takayanagi R; Ito T; Oba K; Nawata H
FEBS Lett; 1997 Dec; 420(1):103-6. PubMed ID: 9450558
[TBL] [Abstract][Full Text] [Related]
15. Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities.
Rizzi A; Calo G; Battistini B; Regoli D
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S58-61. PubMed ID: 9595400
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cells.
Deprez-Roy I; Coge F; Bertry L; Galizzi JP; Feletou M; Vanhoutte PM; Canet E
Acta Pharmacol Sin; 2000 Jun; 21(6):499-506. PubMed ID: 11360683
[TBL] [Abstract][Full Text] [Related]
17. Big endothelin in plasma and amniotic fluid.
Chou J; Wang YN; Chang D; Chang JK; Avila C; Romero R
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S430-3. PubMed ID: 1725402
[TBL] [Abstract][Full Text] [Related]
18. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
Maguire JJ; Kuc RE; Davenport AP
Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
[TBL] [Abstract][Full Text] [Related]
19. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
Yap EY; Battistini B; McKay KO
Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217
[TBL] [Abstract][Full Text] [Related]
20. Phosphoramidon-sensitive endothelin converting enzyme in cultured vascular smooth muscle cells converts big endothelin-3 to endothelin-3.
Tsukahara Y; Matsumura Y; Kuninobu K; Kojima T; Takaoka M; Morimoto S
Life Sci; 1993; 53(6):465-71. PubMed ID: 8341132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
